Adaptive Biotechnologies Corporation
ADPT
$7.49
-$0.25-3.23%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 29.19% | 0.36% | -11.81% | -10.20% | -12.52% |
| Total Depreciation and Amortization | -13.38% | -8.70% | -1.72% | 3.45% | 6.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.73% | 32.35% | 36.14% | 29.68% | 38.89% |
| Change in Net Operating Assets | 62.21% | 54.81% | 45.00% | 56.63% | 35.45% |
| Cash from Operations | 39.09% | 31.21% | 16.67% | 24.14% | 15.02% |
| Capital Expenditure | 65.75% | 59.12% | 49.87% | 42.68% | 34.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.96% | 56.14% | 15.50% | 171.36% | 628.91% |
| Cash from Investing | -40.00% | 103.77% | 31.19% | 294.30% | 4,362.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -89.27% | -91.90% | -94.59% | -72.18% | -71.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -89.27% | -90.71% | -99.86% | -98.76% | -98.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.69% | 60.60% | -248.21% | -12.20% | 49.91% |